Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q1 2023 vs. Q4 2022
How the institutions holding Kiora Pharmaceuticals Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 11 | 14 | +3 |
| Shares | 151.2K | 83.4K | −67.8K (−44.9%) |
| Value | $518.8K | $283.6K | −$235.3K (−45.3%) |
New holders (6)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 21,460 | $70.0K | 0.00% |
| Citadel Advisors LLC | 14,134 | $47.2K | 0.00% |
| Dimensional Fund Advisors LP | 12,254 | $40.9K | 0.00% |
| Bank of Montreal | 10,000 | $40.4K | 0.00% |
| Vanguard Group Inc | 10,503 | $35.1K | 0.00% |
| GWM Advisors LLC | 200 | $668 | 0.00% |
Sold out (3)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Walleye Capital LLC | 83,300 | $285.7K |
| Warberg Asset Management LLC | 33,000 | $113.2K |
| Boothbay Fund Management, LLC | 11,679 | $40.1K |